VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,838,000 | -9.6% | 256,000 | -13.5% | 0.11% | -17.2% |
| Q2 2019 | $7,566,000 | +14.0% | 296,000 | 0.0% | 0.13% | +9.8% |
| Q1 2019 | $6,636,000 | +28.9% | 296,000 | +21.2% | 0.12% | +17.3% |
| Q4 2018 | $5,150,000 | +13.9% | 244,200 | 0.0% | 0.10% | +33.3% |
| Q3 2018 | $4,523,000 | -34.0% | 244,200 | -20.6% | 0.08% | -36.6% |
| Q2 2018 | $6,858,000 | +1.5% | 307,400 | 0.0% | 0.12% | +2.5% |
| Q1 2018 | $6,757,000 | -5.4% | 307,400 | 0.0% | 0.12% | -1.6% |
| Q4 2017 | $7,144,000 | +1.2% | 307,400 | 0.0% | 0.12% | -3.2% |
| Q3 2017 | $7,058,000 | +37.3% | 307,400 | +32.0% | 0.13% | +32.6% |
| Q2 2017 | $5,142,000 | -3.2% | 232,900 | 0.0% | 0.10% | -4.0% |
| Q1 2017 | $5,312,000 | +27.7% | 232,900 | +55.1% | 0.10% | +15.1% |
| Q2 2016 | $4,161,000 | – | 150,164 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |